MDLN PE Ratio & Valuation,Is MDLN Overvalued — Intellectia
MDLN Relative Valuation
MDLN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MDLN is overvalued; if below, it's undervalued.
Historical Valuation
No data
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MDLN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of MDLN in the past 1 year is driven by Unknown.
Is Medline Inc. (MDLN) currently overvalued or undervalued?
Medline Inc.(MDLN)is now in theFairzone, suggesting that its currentforward PEratio of NaNis consideredFairlycompared with the five-year average of.The fair price of Medline Inc.(MDLN)is betweentoaccording to relative valuation methord.
What is Medline Inc. (MDLN) fair value?
MDLN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Medline Inc. (MDLN) is between to according to relative valuation methord.
How does MDLN's valuation metrics compare to the industry average?
The average P/S ratio for MDLN's competitors is , providing a benchmark for relative valuation. Medline Inc. Corp (MDLN) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Medline Inc. (MDLN) as of Dec 17 2025?
As of Dec 17 2025, Medline Inc. (MDLN) has a P/B ratio of NaN. This indicates that the market values MDLN at NaN times its book value.
What is the current FCF Yield for Medline Inc. (MDLN) as of Dec 17 2025?
As of Dec 17 2025, Medline Inc. (MDLN) has a FCF Yield of NaN%. This means that for every dollar of Medline Inc.’s market capitalization, the company generates NaN cents in free cash flow.
What is the current Forward P/E ratio for Medline Inc. (MDLN) as of Dec 17 2025?
As of Dec 17 2025, Medline Inc. (MDLN) has a Forward P/E ratio of NaN. This means the market is willing to pay $NaN for every dollar of Medline Inc.’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Medline Inc. (MDLN) as of Dec 17 2025?
As of Dec 17 2025, Medline Inc. (MDLN) has a Forward P/S ratio of NaN. This means the market is valuing MDLN at $NaN for every dollar of expected revenue over the next 12 months.
